Session 12 Anticoagulants Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What do anticoagulation drugs aim to do?

A

prevent thrombus formation and thrombus growing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is regulation of the coagulation cascade essential for?

A

regulation is essential to prevent solidification of all blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are coagulation factors present in blood as?

A

they are present in blood as inactive zymogens, serine proteases and cofactors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

where in the body are heparins produced naturally?

A

mast cells and vascular endothelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does unfractionated heparin work?

A

UFH accelerates interaction of antithrombin with both thrombin and factor Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

To catalyse inhibition of thrombin (IIa), what does heparin need to do?

A

simultaneously bind antithrombin(III) and thrombin(IIa)

NB: Xa inhibition only needs antithombin(III) binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are two examples of low molecular weight heparins?

A

dalteparin

enoxaparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pharmacokinetics of heparin (table in slides)
UFH vs LMWH

Dose response = 
Bioavailability = 
Metabolism = 
Monitoring = 
Administration = 
Initiation = 
Half life = 
Action = 
Use =
A

Dose response = non-linear vs predictable
Bioavailability = s.c. variable vs predictable
Metabolism = dose dependent (protein binding, depolymerisation, desulfation - 1st and 0 order) vs rapid liver or slower renal excretion
Monitoring = unpredictable (look at aPTT) vs no monitoring just U/kg dosing
Administration = intravenous infusion (S.C) vs S.C (NOT IM)
Initiation = IV bolus then IVI vs OB/BC s.c
Half life = 30 min low dose, 2h high dose vs 2+h
Action = IVI fast anticoagulation vs s.c. slower onset
Use = severe renal impairment and fine control vs most situations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Some indications for the use of heparins?

A

PREVENTION of venous thromboembolism
(perioperative prophylaxis with LMWH and dose is dependent on risk)

Can be used during pregnancy as it does not cross placenta - although needs to be monitored with caution

Acute Coronary Syndromes
short term - can reduce recurrence and/or extension of coronary artery thrombosis post STEMI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ADR’s related to heparins?

A

bruising and bleeding = most common

  • location = intracranial, at site of injection, GI, nose bleed (epistaxis)
  • higher risk if hepatic or renal impairment present, elderly or in those with carcinoma

heparin induced thrombocytopenia (HIT)
* more common with UFH (compared with LMWH)

hyperkalaemia
* as there is inhibition of aldosterone secretion

osteoporosis = least common

  • from long-term use
  • higher risk with UFH
  • more prevalent in pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does heparin induced thrombocytopenia (HIT) occur?

A

if there is an autoimmune response 2-14 days after initiation of heparin

antibodies produced to heparin platelet factor 4 complex –> depletion of platelets

this can paradoxically lead to thrombosis as more platelets are activated by damaged endothelium :(

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

when would you use protamine sulphate and how does it work?

A

given to reverse the effects of heparin

it forms an inactive complex with heparin and dissociates the heparin from antithrombin(III)

irreversible binding

amount given (IV) guided by the dose of heparin

but can cause bleeding! - perform an in vitro test if unsure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which type of heparin does protamine sulphate have more of an effect on?

A

UFH = greater effect than LMWH

NO effect on fondaparinux

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do vitamin K antagonists work?

A

inhibit activation of vitamin K dependent clotting factors

inhibits conversion of vitamin K to active reduced form
competitive inhibition of VK epoxide reductase = VKOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which drug is a vitamin K antagonist?

A

warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

hepatic synthesis of WHICH clotting factors require active vitamin K as a cofactor?

A

II
VII
IX
X

2, 7, 9, 10

17
Q

half-life of warfarin?

A

36-48 hours

day and a half - two days

18
Q

What are some indications for the use of warfarin?

A

venous thromboembolism
PE
DVT and secondary prevention
superficial vein thrombosis

atrial fibrillation with high risk of stroke

heart valve replacement

used in longer term anticoagulation

NB: slow onset of action likely to require heparin cover if anticoagulation needed immediately (acute settings)

19
Q

Outline the pharmacokinetics of warfarin

A

GI absorption = good
Taken = orally (bioavailability = 95%)
Significant inter individual variability due to: functional CYP2C9 polymorphisms
warfarin is a racemic mixture of two enantiomers: R and S = have different potency and are metabolised differently

20
Q

What is the response of warfarin affected by?

A

CYP2C9

Vitamin K intake

21
Q

Can warfarin be used in pregnancy?

A

NO

avoided at least in 1st trimester = teratogenic
and in 3rd trimester = haemorrhage risk

22
Q

ADR’s of warfarin?

A

MAIN = BLEEDING

epistaxis and spontaneous retroperitoneal bleeding

23
Q

What is the most effective warfarin antidote?

A

Vitamin K1

plus STOP the warfarin!

24
Q

What is often required when initiating or temporarily stopping warfarin?

A

bridging therapy with LMWH

25
Q

drug-drug interactions of warfarin?

A

there are loads! - the majority potentiate anticoagulation action but some do decrease the effects

amiodarone, clopidogrel, intoxicating dose of alcohol, quinolone, metronidazole - inhibition of hepatic metabolism (CYP2C9)

cephalosporins - reduce vitamin K by eliminating gut bacteria involved in production

NSAIDS and drugs that decrease GI absorption of vitamin K - displacement of warfarin from plasma albumin –> INCREASE INR

barbiturates, phenytoin, rifampicin, st johns wort - acceleration of warfarin metabolism –> DECREASE INR

26
Q

why is monitoring required in those that take warfarin?

A

as there is a huge variation in patient response

27
Q

which factor is most sensitive to vitamin K deficiency?

A

factor VII

so used in prothrombin time

28
Q

what does INR demonstrate?

A

clotting time vs standard clotting time

* allows for standard corrected value compared across all laboratories

29
Q

which INR values would indicate that warfarin should be used?

A

INR 2.5

  • DVT
  • PE
  • AF (risk vs benefit)

INR 3-3.5
* recurrent DVT or PE in patients currently receiving anticoagulation

30
Q

What are names of some direct acting oral anticoagulants? (DOAC) - direct Xa

A

apixaban
edoxaban
rivaroxaban

31
Q

How do DOAC’s work? (direct Xa)

A

inhibit both free Xa AND Xa that is bound with antithrombin(III)

NB: do not directly effect thrombin (IIa)

32
Q

DOAC (direct Xa)

metabolism =
excretion =
half-life =

A
metabolism = hepatic
excretion = partly by kidneys
half-life = 10 hours
33
Q

DOAC (direct IIa) MoA?

A

selective direct competitive thrombin inhibitor of both circulating AND thrombus bound thrombin(IIa)

34
Q

DOAC (direct IIa)

name of drug =
admin =
half-life =
dosing and monitoring =

A

name of drug = dabigatran
admin = oral
half-life = 9 hours
dosing and monitoring = standard dosing and no direct monitoring required

35
Q

Advantages and disadvantages of DOAC?

A

good

  • less frequent interactions than warfarin
  • lower intracranial bleed risk than warfarin
  • antidotes available (andexanet and idarucizumab)
  • metabolism and elimination by several routes

bad

  • bleeding (caution in GI bleed risk groups)
  • dabigatran contraindicated in low creatinine clearance
  • affected by CYP inhibitors
  • plasma conc. reduced by: carbamazepine, phenytoin and barbiturates
  • plasma conc. increased by: macrolides
  • little information in use in pregnancy and breastfeeding so AVOID